Skip to main content
Michael  Greeley

Michael Greeley
General Partner, Flybridge Capital Partners

Michael is a General Partner at Flybridge Capital Partners and is excited about investment opportunities involving the convergence of healthcare and information technologies, as well as in the specialty finance and business services industries. One of his current investment themes is around the application of “Big Data” platforms across a number of industry verticals. Previously, Michael was with Polaris Venture Partners, where he focused on both early-stage and later-stage financings for emerging growth companies. Before Polaris, Michael served as Senior Vice President and Founding Partner of GCC Investments, was a Vice President and one of the early professionals at Wasserstein Perella & Co., was a member of the Mergers and Acquisitions Department of Morgan Stanley & Co. and worked in the Leveraged Buyout Group of Credit Suisse First Boston.

Michael currently serves as Chair of the Entrepreneurship Committee of the Massachusetts Information Collaborative, as co-Founder of the 12×12 program, on the board of the New England Investors’ Committee of Capital Innovation, and was recently appointed a Venture Capital Consultant for the Defense Venture Catalyst Initiative (DeVenCI), an initiative for the Department of Defense. He previously served on the board and Executive Committee of the National Venture Capital Association and as Chairman and President of the New England Venture Capital Association.
Michael received a BA with honors in Chemistry from Williams College and an MBA from Harvard Business School.


Deal-Flow Salon F
Bijan Salehizadeh (Navimed Capital), Anthony Gerardi (Truven Health), Michael Greeley (Flybridge Capital Partners)
Venture financing, M&A, and IPOs are now starting to become commonplace in the healthcare data & analytics and Health IT markets, becoming one of the fastest growing sectors for deal flow, and outpacing growth in more traditional drug development and medical device markets. What’s driving this trend, who will be the winners and losers, and where is the market headed? Read more.

For exhibition and sponsorship opportunities at Strata Rx conference, contact Sharon Pierce at (203) 304-9476 or

For information on trade opportunities with O'Reilly conferences email mediapartners

View a complete list of Strata Rx 2013 contacts